We help life sciences companies navigate complex health technology assessments and unlock market access opportunities with confidence. From evidence generation strategies to tailored market access plans, ELC combines deep expertise with a personalised approach. We deliver actionable insights that accelerate approvals and maximise product value.

Discover Our Services

01Starting off

Vestibulum ultricies erat vitae faucibus vulputate. Sed finibus ipsum eu nibh volutpat, in congue sapien lorem.

02Starting off

Vestibulum ultricies erat vitae faucibus vulputate. Sed finibus ipsum eu nibh volutpat, in congue sapien lorem.

03Starting off

Vestibulum ultricies erat vitae faucibus vulputate. Sed finibus ipsum eu nibh volutpat, in congue sapien lorem.

Expert Guidance at Every Stage: From Innovation to Patient Access

ELC offers an unparalleled range of services tailored to meet the needs of our clients, support their big decisions, solve their complex problems and maximise their chances of getting to market.

HTA Evidence Generation Advice (HEGA)

Plan for a positive HTA outcome by getting your evidence development and HTA and market access strategies right from the outset. Our experts will provide answers to critical evidence-related questions. We will identify your evidence development plans’ strengths, gaps, and limitations and recommend options to improve and de-risk them for HTA and market access decision-makers. 

HTA and Market Access Strategy Development 

We provide strategic advice and counsel on navigating the complexities of evidence development, HTA and market access in the UK and across Europe. We develop HTA and market access strategies and facilitate discussions with key stakeholders and decision-makers to accelerate and optimise patient access to new treatments, diagnostics and devices. 

Evidence Gap Analysis

Our team examines a technology’s evidence, replicating the scrutiny applied by HTA bodies. We identify the evidence’s strengths, gaps, and limitations and recommend options to improve it, including using examples of previous similar appraisals. In discussion with the company, we provide detailed insights on methodological and process steps that should be taken to improve HTA approval chances and patient access. 

Economic Model Validation

We provide an independent quality assessment and robust critique of early and fully completed health economic models. Clients will receive a technical report detailing findings and recommendations for improvement and optimisation and a two-hour workshop to discuss the report.

Advisory Boards

We design and deliver Advisory Boards by bringing together healthcare professionals, payers, patients, patient organisations, market access and health economics experts to test evidence-development plans and value propositions. An Advisory Board will increase your understanding of the therapeutic area, treatment pathways, comparators and service implications in the context of local decision-making and health systems. 

Value Dossiers and Objection Handlers

We are experts in creating HTA Value Dossiers and Objection Handlers to demonstrate to decision-makers and potential users the value a new technology can bring and how it will be positioned relative to other technologies. 

Therapeutic Area Landscape Analyses 

We evaluate the healthcare environment in which your technology will be used, including government policy, key clinical guidelines, professional and patient associations, and other relevant topics impacting access. Our approach involves a literature review, relevant policy analysis, in-depth interviews with experts, and assessing the impact of other clinical developments.

HTA Therapeutic Area Deep Dives

Deep Dives provides curated insights and reflections from hundreds of previous HTAs in the same or similar therapeutic areas. Our insights and recommendations reflect a deep understanding of evidence development, HTA methods and processes, HEOR, the competitive landscape, the therapeutic area market and evolving treatment pathways. They will inform you of your evidence development, HTA and market access strategies and tactics. 

Therapeutic Area Monitoring

We provide continuous, detailed, actionable insights into therapeutic area pipelines, competitor activity, and your competitive environment to inform your development, HTA and market access strategies, tactics and decisions. We utilise primary, secondary, and other research methods, competitor intelligence and contextual analysis, alongside decades of experience from our expert team.

HTA and Market Access Training 

We provide bespoke training for clients engaged in evidence development, market access, and HTA activities to better understand HTA methods and processes in the UK and across Europe. 

Mock HTA Appraisals

We deliver an authentic, intensive mock appraisal to stress test strategy and approach ahead of HTA Appraisal Committee Meetings. The mock appraisal panel will consist of experienced cost, clinical and lay members, as well as patient and clinical experts, to provide a realistic environment. A detailed set of recommendations are provided following the mock meeting, giving critical feedback at the optimum time.

Get in touch

We’re here to help. Share your details, and we will explore how we can work together.

Contact Us